Covid-19: Vaccine Shows Immune Response at All Doses, Phase III Trial to Launch July 27
No trial-limiting safety concerns were reported The Covid-19 vaccine farthest along in clinical...
Read More
FDA / Research
Covid-19: TB Vaccination May Protect Against Death
Preliminary study finds countries with BCG vaccine programs have lower Covid-19 mortality...
Read More
Conference Highlights – AIDS 2020: Virtual – A Focus on COVID-19
New research was presented at AIDS 2020: Virtual, the 23rd International AIDS Conference, from...
Read More
Covid-19: School-Age Kids Don’t Seem to Drive Infections
Swiss study indicates school-based transmission may not necessarily be cause for concern The kids...
Read More
Risk for COVID-19 Increased for Adults Taking PPIs
FRIDAY, July 10, 2020 (HealthDay News) — Adults taking proton pump inhibitors (PPIs) have an...
Read More
Emphasizing Severity of COVID-19 Important for Teen Behaviors
FRIDAY, July 10, 2020 (HealthDay News) — For adolescents, understanding the severity of...
Read More
COVID-19 Explored in Kidney Recipients, Hemodialysis Patients
FRIDAY, July 10, 2020 (HealthDay News) — Many outpatient kidney transplant recipients with...
Read More
Incidence of Takotsubo Cardiomyopathy Up During COVID-19
FRIDAY, July 10, 2020 (HealthDay News) — The incidence of Takotsubo cardiomyopathy has...
Read More
Gilead Presents Additional Data on Efficacy of Remdesivir for COVID-19
FRIDAY, July 10, 2020 (HealthDay News) — There is more good news on the effectiveness of the...
Read More
WHO to Lead Investigation of COVID-19 Pandemic Origins
FRIDAY, July 10, 2020 (HealthDay News) — The World Health Organization will lead an...
Read More
Analysis: How A COVID-19 Vaccine Could Cost Americans Dearly
The United States is the only developed nation unable to balance cost, efficacy and social good in setting prices.
Read More
Coronavirus Crisis Disrupts Treatment For Another Epidemic: Addiction
The coronavirus has forced drug rehabilitation centers to scale back operations or temporarily close, leaving people who have another potentially deadly disease — addiction — with fewer opportunities for help.
Read More
Study Finds DMTs for MS Don’t Increase Risk for Severe Covid-19
Risk factors for severe disease are age, disability, or obesity Multiple sclerosis (MS) patients...
Read More
Breaking Covid-19: Hydroxychloroquine Down But Not Yet Out?
Study from Henry Ford shows promise in select patients Lynne Peterson is the Senior Writer for...
Read More
Majority of Patients with Mild Covid-19 Experience Altered Smell/Taste
1-in-10 patients in study from Italy experienced persistent symptoms Among an early cohort of...
Read More
Point-Prevalence Surveys in SNFs Help Cut COVID-19 Transmission
THURSDAY, July 2, 2020 (HealthDay News) — Conducting point-prevalence surveys in skilled...
Read More
EMS Calls Down Early in COVID-19 Outbreak
THURSDAY, July 2, 2020 (HealthDay News) — Early in the COVID-19 outbreak there was a...
Read More
Neurological Symptoms Described in Children With COVID-19
THURSDAY, July 2, 2020 (HealthDay News) — Children with COVID-19 may present with new...
Read MoreHydroxychloroquine Cuts Mortality by 50%
DETROIT – Treatment with hydroxychloroquine cut the death rate significantly in sick patients hospitalized with COVID-19 – and without heart-related side-effects, according to a new study published by Henry Ford Health System....
Read More
Model May Help Predict Risk for Testing Positive for COVID-19
THURSDAY, June 25, 2020 (HealthDay News) — It is possible to predict the likelihood of...
Read More